Want to see JP:7679 full AI Analyst Report?
7679 Stock Chart & Stats
¥2167.00
-¥102.00(-4.91%)
At close: 4:00 PM EST
¥2167.00
-¥102.00(-4.91%)
Day’s Range― - ―
52-Week Range¥1,609.00 - ¥2,332.00
Previous CloseN/A
Volume101.50K
Average Volume (3M)32.44K
Market Cap
¥33.48B
Enterprise Value¥53.22K
Total Cash (Recent Filing)¥6.87B
Total Debt (Recent Filing)¥26.61B
Price to Earnings (P/E)8.4
Beta0.41
Next Earnings
Oct 01, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield1.72%
Share Statistics
EPS (TTM)200.86
Shares Outstanding19,740,220
10 Day Avg. Volume22,110
30 Day Avg. Volume32,443
Financial Highlights & Ratios
PEG Ratio-1.88
Price to Book (P/B)1.01
Price to Sales (P/S)0.25
P/FCF Ratio-4.91
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Consistent Revenue GrowthSustained mid-to-high single-digit top-line expansion over multiple years builds scale in procurement and merchandising for the drugstore network. That durable revenue trend supports predictable cash inflows, improves negotiating leverage with suppliers, and underpins long-term planning and store investment.
Built Equity / Solid Capital BaseA steadily accumulated equity base provides a structural cushion for retail operations, enabling resilience through demand cycles and supporting capital allocation for store upkeep or targeted expansion. Strong equity reduces insolvency risk and helps secure financing on better terms over time.
Consistent Operating ProfitabilityStable, if thin, net margins indicate the core retail model consistently converts sales to operating profit, reflecting recurring demand for pharmaceuticals and daily goods. Predictable profitability supports ongoing operations, modest dividends and gives management time to address structural cost pressures.
Bears Say
Sharp Debt Increase In 2026A marked rise in leverage materially increases interest and refinancing risk for a retail business with thin margins. Higher debt restricts strategic flexibility, raises the break-even threshold for new stores or productivity investments, and can pressure credit metrics if cash generation weakens.
Volatile And Negative Free Cash FlowRecurrent swings into negative free cash flow reduce the firm's ability to self-fund capex, debt service, or dividends. Reliance on external funding to cover investments or working capital raises long-term financing costs and increases vulnerability if credit conditions tighten.
Margin Compression TrendEroding gross and EBITDA margins point to rising input costs or competitive pricing pressure in the drugstore sector. Persistent margin compression undermines cash flow generation and returns on new stores, forcing either structural cost cuts or shifts in product mix to restore sustainable profitability.
Yakuodo Holdings Co., Ltd. News
7679 FAQ
What was Yakuodo Holdings Co., Ltd.’s price range in the past 12 months?
Yakuodo Holdings Co., Ltd. lowest stock price was ¥1609.00 and its highest was ¥2332.00 in the past 12 months.
What is Yakuodo Holdings Co., Ltd.’s market cap?
Yakuodo Holdings Co., Ltd.’s market cap is ¥33.48B.
When is Yakuodo Holdings Co., Ltd.’s upcoming earnings report date?
Yakuodo Holdings Co., Ltd.’s upcoming earnings report date is Oct 01, 2026 which is in 34 days.
How were Yakuodo Holdings Co., Ltd.’s earnings last quarter?
Yakuodo Holdings Co., Ltd. released its earnings results on Jul 06, 2026. The company reported ¥51.33 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Yakuodo Holdings Co., Ltd. overvalued?
According to Wall Street analysts Yakuodo Holdings Co., Ltd.’s price is currently Overvalued.
Does Yakuodo Holdings Co., Ltd. pay dividends?
Yakuodo Holdings Co., Ltd. pays a Annually dividend of ¥30 which represents an annual dividend yield of 1.72%. See more information on Yakuodo Holdings Co., Ltd. dividends here
What is Yakuodo Holdings Co., Ltd.’s EPS estimate?
Yakuodo Holdings Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Yakuodo Holdings Co., Ltd. have?
Yakuodo Holdings Co., Ltd. has 19,740,220 shares outstanding.
What happened to Yakuodo Holdings Co., Ltd.’s price movement after its last earnings report?
Yakuodo Holdings Co., Ltd. reported an EPS of ¥51.33 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 2.51%.
Which hedge fund is a major shareholder of Yakuodo Holdings Co., Ltd.?
Currently, no hedge funds are holding shares in JP:7679
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Yakuodo Holdings Co., Ltd.
YAKUODO HOLDINGS Co., Ltd., through its subsidiaries, engages in drugstore business in Japan. It retails health products, including energy drinks, cold medicine, disposable diapers for nursing care, and sanitary products; beauty products comprising skincare, cosmetics, and hair and oral care products; home products, such as detergents and household paper; and food products that include frozen food, beer, and chuhai. The company was founded in 1978 and is headquartered in Morioka, Japan.
Technical Analysis
Sundrug Co
―
Sugi Holdings Co
―
TSURUHA Holdings
―
COSMOS Pharmaceutical Corporation
―
KUSURI NO AOKI HOLDINGS CO.,LTD.
―